Subbarao V Uppaluri - Net Worth and Insider Trading

Subbarao V Uppaluri Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Subbarao V Uppaluri owns 4 companies in total, including BioCardia Inc (BCDA) , OPKO Health Inc (OPK) , and Winston Pharmaceuticals Inc (WPHM) among others .

Click here to see the complete history of Subbarao V Uppaluri’s form 4 insider trades.

Insider Ownership Summary of Subbarao V Uppaluri

Ticker	Comapny	Transaction Date	Type of Owner
BCDA	BioCardia Inc	2008-09-19	director
OPK	OPKO Health Inc	2007-02-09	director
WPHM	Winston Pharmaceuticals Inc	2010-05-19	director
NIMU	Non-Invasive Monitoring Systems Inc	2009-02-23	director

Subbarao V Uppaluri Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Subbarao V Uppaluri Ownership Network

Ownership Network List of Subbarao V Uppaluri

No Data

Ownership Network Relation of Subbarao V Uppaluri

Subbarao V Uppaluri Owned Company Details

What does BioCardia Inc do?

Who are the key executives at BioCardia Inc?

Subbarao V Uppaluri is the director of BioCardia Inc. Other key executives at BioCardia Inc include 10 percent owner Frost Phillip Md Et Al , 10 percent owner Frost Gamma Investments Trust , and Senior Vice President & Devices Edward M Gillis .

BioCardia Inc (BCDA) Insider Trades Summary

Over the past 18 months, Subbarao V Uppaluri made no insider transaction in BioCardia Inc (BCDA). Other recent insider transactions involving BioCardia Inc (BCDA) include a net purchase of 465,436 shares made by Frost Phillip Md Et Al ,

In summary, during the past 3 months, insiders sold 0 shares of BioCardia Inc (BCDA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 129,802 shares of BioCardia Inc (BCDA) were sold and 595,238 shares were bought by its insiders, resulting in a net purchase of 465,436 shares.

BioCardia Inc (BCDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

BioCardia Inc Insider Transactions

No Available Data

What does OPKO Health Inc do?

Who are the key executives at OPKO Health Inc?

Subbarao V Uppaluri is the director of OPKO Health Inc. Other key executives at OPKO Health Inc include 10 percent owner Frost Phillip Md Et Al , director & Chief Innovation Officer Gary J. Nabel , and director & Vice Chairman and President Elias A. Zerhouni .

OPKO Health Inc (OPK) Insider Trades Summary

Over the past 18 months, Subbarao V Uppaluri made no insider transaction in OPKO Health Inc (OPK). Other recent insider transactions involving OPKO Health Inc (OPK) include a net purchase of 12,636,531 shares made by Frost Phillip Md Et Al , a net purchase of 400,010 shares made by Hsiao Jane Ph D , and a net purchase of 676,429 shares made by Gary J. Nabel .

In summary, during the past 3 months, insiders sold 0 shares of OPKO Health Inc (OPK) in total and bought 5,100,000 shares, with a net purchase of 5,100,000 shares. During the past 18 months, 0 shares of OPKO Health Inc (OPK) were sold and 14,388,270 shares were bought by its insiders, resulting in a net purchase of 14,388,270 shares.

OPKO Health Inc (OPK)'s detailed insider trading history can be found in Insider Trading Tracker table.

OPKO Health Inc Insider Transactions

No Available Data

What does Winston Pharmaceuticals Inc do?

Who are the key executives at Winston Pharmaceuticals Inc?

Subbarao V Uppaluri is the director of Winston Pharmaceuticals Inc. Other key executives at Winston Pharmaceuticals Inc include 10 percent owner Frost Phillip Md Et Al , 10 percent owner Frost Gamma Investments Trust , and 10 percent owner Steven Jerry Glauser .

Winston Pharmaceuticals Inc (WPHM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Winston Pharmaceuticals Inc (WPHM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Winston Pharmaceuticals Inc (WPHM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Winston Pharmaceuticals Inc (WPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Winston Pharmaceuticals Inc Insider Transactions

No Available Data

What does Non-Invasive Monitoring Systems Inc do?

Who are the key executives at Non-Invasive Monitoring Systems Inc?

Subbarao V Uppaluri is the director of Non-Invasive Monitoring Systems Inc. Other key executives at Non-Invasive Monitoring Systems Inc include 10 percent owner Frost Phillip Md Et Al , director & 10 percent owner Hsiao Jane Ph D , and director & 10 percent owner & CEO Marvin Arthur Sackner .

Non-Invasive Monitoring Systems Inc (NIMU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Non-Invasive Monitoring Systems Inc (NIMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Non-Invasive Monitoring Systems Inc (NIMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Non-Invasive Monitoring Systems Inc (NIMU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Non-Invasive Monitoring Systems Inc Insider Transactions

No Available Data

Subbarao V Uppaluri Mailing Address

Above is the net worth, insider trading, and ownership report for Subbarao V Uppaluri. You might contact Subbarao V Uppaluri via mailing address: 4400 Biscayne Boulevard, Suite 1500, Miami Fl 33137.

Discussions on Subbarao V Uppaluri

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.